Why the study?
Does rosuvastatin 20 mg improve lipid profiles in patients with primary hypertension and dyslipidemia?
Cross-Sectional (n=116)
No
Does rosuvastatin 20 mg improve lipid profiles in patients with primary hypertension and dyslipidemia?
Answers are grounded in this paper and cite their sources.
Rosuvastatin 20 mg significantly improves lipid profiles, including a 1.69 mmol/L reduction in LDL-C, in patients with primary hypertension and dyslipidemia over 12 weeks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Anh et al. (2021) conducted a cross-sectional in Primary hypertension and dyslipidemia (n=116). Rosuvastatin vs. Before treatment was evaluated on Change in LDL-C concentration (MD 1.69 mmol/L).
Synapse has enriched 10 related papers. Consider them for comparative context: